跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 59 条关于
“Promacta/Revolade”
全部
59
临床试验
43
药物
3
机构
1
资讯
12
2个月前
Novartis Q2 Earnings: Cosentyx and Kisqali Drive Growth Amid Entresto Decline and Generic Pressures
7个月前
Novartis Faces First Profit Decline in Decade as Key Drug Patents Expire
8天前
China Approves Hengrui's Oral TPO-RA Hetrombopag for Thrombocytopenia
去年
Appeals Court Denies Novartis' Bid to Block Generic Entresto, Threatening $5.6B Revenue Stream
去年
First Generic Eltrombopag Launches, Expanding Access for Thrombocytopenia and Aplastic Anemia Patients
11个月前
Dutch Court Blocks Glenmark's Early Generic Eltrombopag Launch, Reinforces SPC Protection
去年
Thrombocytopenia Treatment Market Shows Promising Growth with Novel Therapies and Clinical Trials
去年
FDA Approves 25 First-Time Generic Drugs in First Half of 2025, Expanding Access to Critical Therapies
去年
Royalty Pharma Secures 99.9% Shareholder Approval for $1.1 Billion External Manager Acquisition
去年
GSK and Novartis Complete $16 Billion Asset Swap Deal, Reshaping Both Companies' Strategic Focus
第 1 页,共 2 页
上一页
下一页